[1]
N. Bowers and M. Porosnicu, “Increased PD-L1 Tumor Expression Correlates with High Rate of Response to PD-1 Inhibitors in Patients with Unresectable, Recurrent, and Metastatic Cutaneous Squamous Cell Carcinoma”, J of Skin, vol. 5, no. 1, pp. 22–24, Jan. 2021.